We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App

AI Model Detects Cancer at Lightning Speed through Sugar Analyses

By LabMedica International staff writers
Posted on 04 Jul 2024
Print article
Image: The mass spectrometer can detect different structures of the sugar molecules, called glycans, in cells (Photo courtesy of Lundbergs forskningsstiftelse/Magnus Gotander)
Image: The mass spectrometer can detect different structures of the sugar molecules, called glycans, in cells (Photo courtesy of Lundbergs forskningsstiftelse/Magnus Gotander)

Glycans, which are structures made up of sugar molecules within cells, can be analyzed using mass spectrometry. This technique is particularly useful because these sugar structures can reveal the presence of various cancer types within cells. However, interpreting the data from mass spectrometry, specifically, the fragmentation patterns of glycans, requires meticulous human analysis. This detailed scrutiny can take from several hours to days per sample and is only reliably performed by a handful of highly skilled experts globally, as it involves complex, learned detective work over many years. This need for expert analysis creates a significant bottleneck in utilizing glycan analysis for applications like cancer detection, especially when numerous samples need examination. Researchers have now introduced an artificial intelligence (AI) model that enhances the ability to detect cancer through sugar molecule analysis, proving to be both quicker and more effective than the traditional semi-manual approaches.

The AI model, named Candycrunch, was trained by researchers at the University of Gothenburg (Gothenburg, Sweden) using a vast database containing over 500,000 examples of various fragmentations and associated structures of sugar molecules. This extensive training has equipped Candycrunch to accurately determine the precise structure of sugars in a sample in 90% of cases, aiming to soon match the accuracy levels seen in the sequencing of other biological sequences like DNA, RNA, and proteins. The AI model described in a scientific article published in Nature Methods automates glycan analysis and completes it in just a few seconds. Moreover, Candycrunch can identify sugar structures that are typically overlooked by human analysts due to their low concentrations. Due to its speed and precision, Candycrunch significantly speeds up the identification of glycan-based biomarkers, which are crucial for diagnosing and predicting cancer. Thus, the model holds promise in aiding researchers to discover new glycan-based biomarkers for cancer.

“We believe that glycan analyses will become a bigger part of biological and clinical research now that we have automated the biggest bottleneck,” said Daniel Bojar, Associate Senior Lecturer in Bioinformatics at the University of Gothenburg.

Related Links:
University of Gothenburg

Platinum Member
Flu SARS-CoV-2 Combo Test
OSOM® Flu SARS-CoV-2 Combo Test
Magnetic Bead Separation Modules
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Dengue Virus Test

Print article



view channel
Image: The Truvian diagnostic platform combines clinical chemistry, immunoassay and hematology testing in a single run (Photo courtesy of Truvian Health)

Automated Benchtop System to Bring Blood Testing To Anyone, Anywhere

Almost all medical decisions are dependent upon laboratory test results, which are essential for disease prevention and the management of chronic illnesses. However, routine blood testing remains limited worldwide.... Read more


view channel
Image: The Simplexa C. auris direct kit is a real-time polymerase chain reaction assay run on the LIAISON MDX instrument (Photo courtesy of Diasorin)

Novel Molecular Test to Help Prevent and Control Multi Drug-Resistant Fungal Pathogen in Healthcare Settings

Candida auris (C. auris) is a rapidly emerging multi drug-resistant fungal pathogen that is commonly found in healthcare environments, where it presents a challenge due to its ability to asymptomatically... Read more


view channel
Image: Color-enhanced scanning electron micrograph showing Salmonella Typhimurium (red) invading cultured human cells (Photo courtesy of Rocky Mountain Laboratories, NIAID, NIH)

AI Identifies Drug-Resistant Typhoid-Like Infection from Microscopy Images within Hours

Antimicrobial resistance is becoming a serious global health concern, making many infections increasingly difficult to treat and limiting available treatment options. This escalation in resistance raises... Read more


view channel
Image: Beckman Coulter will utilize the ALZpath pTau217 antibody to detect key biomarker for Alzheimer\'s disease on its DxI 9000 immunoassay analyzer (Photo courtesy of Beckman Coulter)

Beckman Coulter Licenses Alzpath's Proprietary P-tau 217 Antibody to Develop Alzheimer's Blood Test

Cognitive assessments have traditionally been the primary method for diagnosing Alzheimer’s disease, but this approach has its limitations as symptoms become apparent only after significant brain changes... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.